Correlation of increase in phosphene threshold with reduction of migraine frequency: a comment.
Bigal
Marcelo E
ME
D000344:Afferent Pathways / Q000378:metabolism / Q000503:physiopathology; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism / Q000503:physiopathology*; D018836:Inflammation Mediators / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008881:Migraine Disorders / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*; D009479:Neuropeptides / Q000378:metabolism*; D009619:Nociceptors / Q000378:metabolism; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology*; D000068797:Orexins; D010719:Phosphenes / Q000502:physiology; D012684:Sensory Thresholds / Q000502:physiology; D014278:Trigeminal Nuclei / Q000378:metabolism / Q000503:physiopathology
D018836:Inflammation Mediators; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins